Clinical Trial Update: Tolerability of Enecadin (INN) in Acute Ischemic Stroke Trial - TEST [Phase 2]

View source ↗

Summary

Phase 2 trial TEST evaluating tolerability of Enecadin in acute ischemic stroke was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Enecadin (Enecadin)

Snippet

Sponsor: PAION Deutschland GmbH | Conditions: Stroke | Phase 2 | Status: TERMINATED